The Current Ratio as of November 2024 (TTM) for Portage Biotech Inc. (PRTG) is 1.73

According to Portage Biotech Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.73. This represents a change of -24.62% compared to the average of 2.29 of the last 4 quarters.

Portage Biotech Inc. (PRTG) Historical Current Ratio (quarterly & annually)

How has PRTG Current Ratio performed in the past?

The mean historical Current Ratio of Portage Biotech Inc. over the last ten years is 66.97. The current 1.73 Current Ratio has changed 158.19% with respect to the historical average. Over the past ten years (40 quarters), PRTG's Current Ratio was at its highest in in the September 2017 quarter at 1.37K. The Current Ratio was at its lowest in in the September 2020 quarter at 1.01.

Portage Biotech Inc. (PRTG) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Portage Biotech Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Portage Biotech Inc. (PRTG) Average Current Ratio

How has PRTG Current Ratio performed in the past?

The current Current Ratio of Portage Biotech Inc. (PRTG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Portage Biotech Inc. (PRTG) Current Ratio vs. Peers

How is PRTG’s Current Ratio compared to its peers?

Portage Biotech Inc.’s Current Ratio is less than Amylyx Pharmaceuticals, Inc. (4.55), less than Karuna Therapeutics, Inc. (19.31), less than Blueprint Medicines Corporation (3.32), less than Arvinas, Inc. (4.17), less than Aerovate Therapeutics, Inc. (8.78), less than Eliem Therapeutics, Inc. (60.41), less than Anebulo Pharmaceuticals, Inc. (3.45), less than Cue Biopharma, Inc. (2.22), less than Decibel Therapeutics, Inc. (4.81), less than Keros Therapeutics, Inc. (19.03), less than Janux Therapeutics, Inc. (38.80), less than Fennec Pharmaceuticals Inc. (7.80), less than Edgewise Therapeutics, Inc. (26.35), less than Harmony Biosciences Holdings, Inc. (3.24), less than Lineage Cell Therapeutics, Inc. (2.48), less than MAIA Biotechnology, Inc. (2.56), greater than Armata Pharmaceuticals, Inc. (0.19), less than Frequency Therapeutics, Inc. (4.42), less than Day One Biopharmaceuticals, Inc. (14.62), less than Acumen Pharmaceuticals, Inc. (10.43), less than X4 Pharmaceuticals, Inc. (4.89), less than Inozyme Pharma, Inc. (7.68), less than VectivBio Holding AG (9.14),

Build a custom stock screener for Portage Biotech Inc. (PRTG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Portage Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Portage Biotech Inc. (PRTG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Portage Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.